Siddiqui Osama M, Baskaran Archit B, Lin Katherine A, Najam Naela, Shah Tahir, Beestrum Molly L, Thuluvath Avesh, Bonakdarpour Borna, Kim Minjee, Dietch Zachary, Wolf Michael, Ladner Daniela P
Northwestern University Transplant Outcomes Research Collaborative (NUTORC), Comprehensive Transplant Center (CTC), Feinberg School of Medicine, Northwestern University, Chicago, IL.
Department of Neurology, University of Chicago Medical Center, University of Chicago, Chicago, IL.
Transplant Direct. 2023 Apr 20;9(5):e1479. doi: 10.1097/TXD.0000000000001479. eCollection 2023 May.
Cognitive impairment is common among patients with cirrhosis and may persist post-transplantation. This systematic review seeks to (1) describe the prevalence of cognitive impairment in liver transplant (LT) recipients with a history of cirrhosis, (2) describe risk factors for this population, and (3) describe associations between post-transplant cognitive impairment and quality outcome measures.
Studies in PubMed, Embase, Scopus, PsychINFO, and the Cochrane Database of Controlled Trials were included through May 2022. Inclusion criteria included (1) population - LT recipient, age ≥18 y, (2) exposure - history of cirrhosis before transplant, and (3) outcome - cognitive impairment after transplant (per validated cognitive testing). Exclusion criteria included (1) wrong study type, (2) abstract-only publication, (3) full-text unavailable, (4) wrong population, (5) wrong exposure, and (6) wrong outcome. The risk of bias was assessed using the Newcastle-Ottawa Scale and the Appraisal tool for Cross-Sectional Studies. The Grading of Recommendations, Assessment, Development, and Evaluations system was used to assess evidence certainty. Data from individual tests were categorized into six cognitive domains: attention, executive function, working memory, long-term memory, visuospatial, and language.
Twenty-four studies were included covering 847 patients. Follow-up ranged from 1 mo to 1.8 y after LT. Studies had a median of 30 (interquartile range 21.5-50.5) patients. The prevalence of cognitive impairment after LT ranged from 0% to 36%. Forty-three unique cognitive tests were used, the most common being the Psychometric Hepatic Encephalopathy Score. The most frequently assessed cognitive domains were attention (10 studies) and executive function (10 studies).
The prevalence of cognitive impairment after LT varied across studies depending on cognitive tests utilized and follow-up duration. Attention and executive function were most impacted. Generalizability is limited due to small sample size and heterogeneous methodology. Further studies are needed to examine differences in the prevalence of post-LT cognitive impairment by etiology, risk factors, and ideal cognitive measures.
认知障碍在肝硬化患者中很常见,并且可能在移植后持续存在。本系统评价旨在:(1)描述有肝硬化病史的肝移植(LT)受者中认知障碍的患病率;(2)描述该人群的危险因素;(3)描述移植后认知障碍与质量结局指标之间的关联。
纳入截至2022年5月在PubMed、Embase、Scopus、PsychINFO和Cochrane对照试验数据库中的研究。纳入标准包括:(1)研究对象——LT受者,年龄≥18岁;(2)暴露因素——移植前有肝硬化病史;(3)结局指标——移植后认知障碍(通过有效认知测试)。排除标准包括:(1)研究类型错误;(2)仅发表摘要;(3)无全文;(4)研究对象错误;(5)暴露因素错误;(6)结局指标错误。使用纽卡斯尔-渥太华量表和横断面研究评估工具评估偏倚风险。采用推荐分级、评估、制定与评价系统评估证据确定性。个体测试数据分为六个认知领域:注意力、执行功能、工作记忆、长期记忆、视觉空间能力和语言。
纳入24项研究,共847例患者。LT术后随访时间为1个月至1.8年。各研究的患者中位数为30例(四分位间距21.5 - 50.5)。LT术后认知障碍的患病率为0%至36%。共使用了43种独特的认知测试,最常用的是心理测量肝性脑病评分。评估最频繁的认知领域是注意力(10项研究)和执行功能(10项研究)。
LT术后认知障碍的患病率因所使用的认知测试和随访时间不同而在各研究中有所差异。注意力和执行功能受影响最大。由于样本量小和方法学异质性,普遍性有限。需要进一步研究以探讨LT术后认知障碍患病率在病因、危险因素和理想认知测量方面的差异。